LUMO
Lumos Pharma, Inc. Common Stock
LUMO
LUMO
Delisted
LUMO was delisted on the 11th of December, 2024.
68 hedge funds and large institutions have $16.1M invested in Lumos Pharma, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
55% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 20
Holders
68
Holding in Top 10
–
Calls
$156K
Puts
$2K
Top Buyers
| 1 | +$998K | |
| 2 | +$489K | |
| 3 | +$309K | |
| 4 |
Renaissance Technologies
New York
|
+$304K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$210K |
Top Sellers
| 1 | -$1.9M | |
| 2 | -$746K | |
| 3 | -$707K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$402K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$371K |